Introduction
- The DARPA IMPAQT ARC Opportunity solicited ideas to explore the following question: What are the applications for a quantum system with N*q > 10,000 as a co-processor for a classical computational system?
- DARPA contracted PolarisQB to expand our Quantum-Aided Drug Design (QuADD) for inhibiting protein-protein interactions (PPIs) for emerging threats.
Advances
- Quantum utility: QAOA continually discovers unique optimal molecules at a steady rate while the classical sampler struggles to find new molecules
- Links to details on Sextant and our hybrid quantum QAOA sampler
- To learn about our wet lab results for small molecules generated with quantum computers, contact us.
